NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.
NewLimit is seeking an Senior/Research Associate with experience in endothelial cell biology to join our Vascular therapeutic team. Our Vascular program is developing reprogramming medicines to restore youthful function in aged endothelial cells for the treatment of renal, cardiometabolic, and cognitive diseases.
Your role will focus on supporting the development of assays and pre-clinical models to measure the functional decline that occurs in endothelial cells with age. You will collaborate closely with our scientists as well as our technology-focused teams to help create the first reprogramming medicines for the vascular tissue.
In your role as a Senior/Research Associate, you will:
NewLimit offers generous benefits to ensure our team can focus on our mission:
Work on cutting-edge sports data and analytics. Join a team that's revolutionizing how we understand sports performance with AI and machine learning.
Salary: $90,000 - $120,000
Interested in building your career at New Limit? Get future opportunities sent straight to your email.
Create AlertDiscover similar positions that might interest you
New Limit
New Limit
New Limit
New Limit